Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Independent Commercialization Generative Optogenetics

Awarded
DARPA-SN-26-27Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Advanced Research Projects Agency (DARPA) is seeking qualified organizations to establish and manage three specialized working groups focused on the responsible development, regulation, and commercialization of Generative Optogenetics (GO), a novel bioengineering platform that enables direct genetic programming of living cells using optical stimuli. This initiative, issued under the Broad Agency Announcement HR001126S0003, targets facilitators for the Independent Commercialization Working Group (ICCG), the Biosecurity Working Group (BSWG), and the Regulatory Policy Working Group (RPWG), each tasked with identifying technical, ethical, and market barriers to advance GO technologies from laboratory innovation to real-world application. Proposals must be submitted in two phases: an abstract by January 26, 2026, followed by a full proposal by March 2, 2026, with submission via DARPA’s Broad Agency Announcement Tool or Grants.gov depending on the award instrument selected. The program spans a 42-month performance period, divided into two phases, with primary performance occurring in Hadley, Massachusetts, and regular in-person working group meetings scheduled in Arlington, Virginia, and the San Francisco Bay Area. Contract awards will be issued under flexible instruments including Procurement Contracts, Cooperative Agreements, or Other Transaction Agreements, with an accelerated award option available for high-quality proposals that can be executed within 30 days of selection. Funding is capped at $1.25 million for BSWG and RPWG proposals and $1.5 million for ICCG proposals, with cost realism and budget justification being critical evaluation criteria. Proposals will be assessed based primarily on scientific and technical merit, followed by proposer capability, alignment with DARPA’s mission to create or prevent technological surprise, and cost credibility—all evaluated through a trade-off process that prioritizes innovation over lowest price. Key requirements include strict separation of personnel between technical performer and working group awards, implementation of firewalls to avoid organizational conflicts of interest, adherence to Controlled Unclassified Information handling protocols for sensitive data presented in meetings, and completion of mandatory training for all participants. Proposers must follow specified templates for abstracts and full proposals, with strict formatting rules including page limits, font sizes, and document structure. All working group participants must undergo vetting for adversarial capital affiliations, sign NDAs, and contribute to deliverables including policy refinement plans, data collection frameworks, event materials, and a final manuscript summarizing policy insights. The contracting office is located in Arlington, Virginia,

General Info

DARPA seeks facilitators to lead three working groups on responsible Generative Optogenetics development across commercialization, biosecurity, and regulatory policy.

Agency

Department Of Defense → Defense Advanced Research Projects AgcyView Agency

Contract Value

$1,400,489

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Hadley, MA, 01035, USA

Set-Aside

NONE

Awardee

NATIONAL COLLEGIATE INVENTORS & INNOVATORS ALLIANCE, INC.View Profile

Award Issued Date

Documents

(2)

Special Notice DARPA-SN-26-27 Generative Optogenetics Working Groups

PDF22 pagesspecial-notice

DARPA-SN-26-27 Generative Optogenetics Abstract Template

ZIP4 pagesspecial-notice

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

special-notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Advanced Research Projects Agcy
Contacts1 person available
OfficeARLINGTON, VA, 222032114, USA
Organization / Agency
Department Of Defense → Defense Advanced Research Projects Agcy
View Agency Profile
Office AddressARLINGTON, VA, 222032114, USA
Contacts
BAA Coordinator

Full Description

Show more
https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=4cac5a7b1adb497d8713e7e413a2d603

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human induced pluripotent stem cell (iPSC)-derived hindbrain organoid functional assay services. The project aims to support in vitro research evaluating drug-induced effects on respiratory-relevant neural circuits over an eighteen-month period of performance. The scope of work is divided into two primary components: the provision of human hindbrain organoids and associated culture materials through twelve scheduled deliveries to the FDA White Oak Campus, and the performance of functional characterization services at the contractor's laboratory. Functional characterization will utilize three-dimensional multi-electrode array (3D MEA) technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Deliverables include the delivery of 96 organoids in the first shipment followed by 48 organoids in subsequent deliveries, as well as raw data, analyzed data, analysis files, and comprehensive study reports. This acquisition is conducted as a commercial service under FAR Part 12, with the government restricting competition based on market research identifying OrganoTherapeutics SARL as the only source capable of meeting the complete requirement for both the specific organoid products and the associated functional assay services.
FDA Office Of Acq Grant Svcs

POSTED

about 13 hours ago

DEADLINE

in 6 days
View Details
NAICS: 541714
New
Federal
Hypoxia Chamber Services
Solicitation # 80JSC026Q0008
NASA Johnson Space Center is soliciting combined synopsis and request for quotations under solicitation 80JSC026Q0008 for Hypoxia Chamber Services to support the Artemis Program. The objective is to investigate the physiological, cognitive, and clinical effects of mild hypobaric hypoxia through two 7-day test protocols involving continuous habitation for six subjects at air equivalent altitudes of 7,000 and 9,500 feet. The scope of work encompasses the provision of infrastructure, personnel, training, materials, and operational support. The contract is structured as a firm fixed price agreement with a base period from September 15, 2026, to September 30, 2027, and multiple option periods extending through March 1, 2030. The acquisition is open to all responsible sources under NAICS code 541714, with a size standard of 1,000 employees. Evaluation is based on a trade-off process where technical acceptability and past performance are significantly more important than price. Proposals must be submitted via email to the designated points of contact by October 1, 2026, following an extension granted in Amendment 0004. Key requirements include the submission of FAR 52.212-3 representations and certifications and adherence to specific submission criteria regarding team qualifications and risk assessment. The contract also incorporates strict guidelines regarding the protection of sensitive information and restrictions on funding activities with China.
NASA Johnson Space Center

POSTED

1 day ago

DEADLINE

in 20 days
View Details
NAICS: 541714
New
Federal
Hypobaric Chamber Pilot Studies
Solicitation # 80JSC026Q0006
NASA Johnson Space Center is soliciting quotes under solicitation 80JSC026Q0006 for pilot hypobaric chamber testing facilities to support decompression sickness research. The primary objective is to validate non-NASA resources for safe prebreathe procedures and extravehicular activity to support Artemis mission planning. The base requirement consists of three test days, with a minimum of two subjects per day, collecting and recording data according to research protocols. The contract also includes six optional work items, including additional test days, inflight-like treatment preparation, elevated metabolic rate testing, pharmaceutical-enhanced prebreathe, and body temperature studies. The base period of performance runs from September 1, 2026, to September 30, 2027, with various option periods extending through March or September 2029. This is a small business set-aside acquisition under NAICS code 541714. Awards will be made based on a trade-off analysis where technical acceptability and past performance are significantly more important than price. Technical evaluation focuses on facility capabilities, medical support, team expertise, and the proposed schedule for subject throughput. Offerors must provide a price quotation using the provided pricing sheet, and quotes must remain valid for at least 90 days. Following several amendments, the final deadline for the submission of offers is October 1, 2026, at 1:00 p.m. Central Time. All submissions must be sent electronically to the designated points of contact.
NASA Johnson Space Center

POSTED

1 day ago

DEADLINE

in 20 days
View Details
NAICS: 541714
Federal
Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability (CADENCC)
Solicitation # W911SR-26-9-CADENCC
The Department of the Army, through the Army Contracting Command Edgewood Contracting Division and the Joint Project Lead Enabling Technologies, is seeking preproposals for the Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability project. This initiative aims to accelerate clinical trial startups for CBRN defense readiness by implementing Master Protocols, utilizing innovative technologies for decentralized trial operations, and establishing a pre-positioned clinical trial site network. The project will primarily focus on Phase I and Phase II clinical trials for early treatment products, post-exposure prophylaxis, and pre-exposure prophylaxis, including those under the Animal Rule. This opportunity is issued under 10 USC 4022 Other Transaction Authority for a prototype project, with the potential for non-competitive follow-on production contracts for successful performers. Preproposals are due by 1500 hours on September 17, 2026, and must be limited to 10 pages. Evaluation will be based on technical merit, military relevance, technology readiness level 4 or above, regulatory compliance with FDA guidelines, and best overall value. Prospective awardees must be registered in the System for Award Management database.
W6QK Acc-Apg

POSTED

8 days ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → Defense Advanced Research Projects Agcy

Same awarding agency

NAICS: 541715
New
Federal
Perrseus
Solicitation # DARPA-PS-26-127
The Defense Advanced Research Projects Agency (DARPA) Multi X Office is soliciting innovative proposals under solicitation DARPA-PS-26-127, titled Perrseus, to develop microscale ultra-high-vacuum systems (uUHV). The program aims to enable compact cold-atom devices and environmentally-decoupled ultra-high Q microelectromechanical (MEMS) and photonics devices, specifically targeting manufacturable vacuum packages with pressures below 10^-10 mbar. The effort is structured as an Other Transaction for Prototype Agreement under 10 U.S.C. 4022, with an estimated period of performance of 42 months starting January 15, 2027. This includes a three-month Phase 0 for security set-up followed by technical development phases. Proposals are evaluated based on overall scientific and technical merit, potential contribution to the DARPA mission, and budget, price, and schedule. Key requirements include CMMC Level 2 self-assessment and strict adherence to Controlled Unclassified Information (CUI) handling guidelines. The program emphasizes low Size, Weight, and Power (SWaP) and high-volume manufacturability. Awardees must deliver ten functional prototypes and undergo in-person government validation of vacuum metrics. The submission process requires a technical and management volume, a detailed price volume, and an oral presentation, with a final proposal deadline of September 23, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

in 11 days
View Details
NAICS: 541715
New
Federal
Precision Inertial Navigation & Positioning On an Integrated Tesseract (PINPOINT)
Solicitation # HR001126S0016
The Precision Inertial Navigation & Positioning On an Integrated Tesseract (PINPOINT) program, solicitation HR001126S0016, is a DARPA initiative seeking revolutionary advances in inertial measurement units (IMUs) for tactical and unmanned missions. The program aims to overcome the performance plateau of micro-electro-mechanical systems (MEMS) by developing novel sensor architectures that operate in highly nonlinear regimes, such as electromagnetically levitated proof masses, non-linear resonators, and high-velocity tethered microsystems. A critical requirement is the tight co-design of the physical sensor package with real-time adaptive control systems to stabilize complex dynamics. The program explicitly excludes evolutionary improvements, focusing instead on revolutionary scientific and systemic breakthroughs. The solicitation allows for multiple award instruments, including procurement contracts, cooperative agreements, and Other Transaction (OT) Agreements. The project is structured in two 24-month phases, with Phase I focusing on mathematical rigor, simulation, and laboratory testing, and Phase II focusing on packaging and environmental ruggedization. Key milestones include a program kick-off in month one, preliminary model reporting by month three, and the delivery of five final hardware IMU samples and a process design kit by month 24. Proposals are evaluated based on overall scientific and technical merit, relevance to the DARPA mission, cost and schedule realism, and the proposer's capabilities. Compliance requirements include CMMC Level 1 and adherence to FAR 52.204-21 for safeguarding contractor information systems. The proposal deadline is October 2, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

in 20 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS